Chemoradiation in Advanced Head and Neck Cancers: A Comparison of two Radiosensitizers, Paclitaxel and Cisplatin (Q35113123)

6 August 2017

title

Chemoradiation in Advanced Head and Neck Cancers: A Comparison of two Radiosensitizers, Paclitaxel and Cisplatin (English)

1 reference

6 August 2017

0 references

1 reference

1 reference

Sohit Paul Kanotra

1

1 reference

6 August 2017

Sonika Kanotra

series ordinal

2

1 reference

6 August 2017

Ashutosh Gupta

series ordinal

3

1 reference

6 August 2017

J Paul

series ordinal

4

1 reference

6 August 2017

language of work or name

1 reference

7 May 2011

1 reference

Indian journal of otolaryngology, and head, and neck surgery : official publication of the Association of Otolaryngologists of India

6 August 2017

published in

1 reference

6 August 2017

volume

63

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

229-236

1 reference

The chemoradiation paradigm in head and neck cancer

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138960

The concurrent chemoradiation paradigm--general principles

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138960

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138960

Reporting results of cancer treatment

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138960

Head and neck cancer: chemotherapy concepts.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138960

Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report of intergroup study 0034

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3138960

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

9 July 2018

1 reference

https://api.crossref.org/works/10.1007/S12070-011-0263-1

Combined postoperative radiotherapy and Weekly Cisplatin infusion for locally advanced head and neck carcinoma: Final report of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12070-011-0263-1

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12070-011-0263-1

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12070-011-0263-1

Phase I/II trial of weekly docetaxel and concomitant radiotherapy for squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12070-011-0263-1

Changes in X-ray Sensitivity of HeLa Cells during the Division Cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12070-011-0263-1

Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17

21 January 2018

1 reference

12 December 2020

A phase II trial of paclitaxel in squamous cell carcinoma of the head and neck with correlative laboratory studies

1 reference

12 December 2020

Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer

1 reference

12 December 2020

An initial experience using concurrent paclitaxel and radiation in the treatment of head and neck malignancies

1 reference

12 December 2020

Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390)

1 reference

12 December 2020

Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer—Results from a phase I trial

1 reference

12 December 2020

X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells

1 reference

12 December 2020

Single agent paclitaxel in advanced squamous cell head and neck carcinoma

1 reference

12 December 2020

1 reference

12 December 2020

A phase I trial of radiotherapy and simultaneous 24-hour paclitaxel in patients with locally advanced head and neck squamous cell carcinoma

1 reference

12 December 2020

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

12 December 2020

Seven-week continuous-infusion paclitaxel with concurrent radiotherapy for locally advanced head and neck squamous cell cancer: a phase I study

1 reference

12 December 2020

Measurable impact: multimodality therapy of head and neck cancer

1 reference

12 December 2020

10.1007/S12070-011-0263-1

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference